Chemotherapy
- 1 May 1997
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 349, S7-S9
- https://doi.org/10.1016/s0140-6736(97)90012-x
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997
- Current perspectives on camptothecins in cancer treatmentBritish Journal of Cancer, 1996
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- Retinoid differentiation therapy in promyelocytic leukemiaThe FASEB Journal, 1996
- Leading Article: Oncologic, Endocrine & Metabolic: New antimetabolites in preclinical and clinical developmentExpert Opinion on Investigational Drugs, 1996
- A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]Blood, 1996
- Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.Journal of Clinical Oncology, 1995
- Post-Remission Treatment of Acute Myelogenous LeukemiaNew England Journal of Medicine, 1995
- The taxoids: paclitaxel and docetaxelThe Lancet, 1994
- Vinorelbine: a horse of a different color?Journal of Clinical Oncology, 1994